Manik Kuchroo is a senior associate at Polaris Partners, focusing on early-stage biotech. He has clinical development and business development experience at Biohaven Pharmaceuticals, Potenza Therapeutics, and Merck & Co.
At firms with a similar stage, sector and check size.





One email when Manik's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckManik Kuchroo is a senior associate at Polaris Partners, focusing on early-stage biotech. He has clinical development and business development experience at Biohaven Pharmaceuticals, Potenza Therapeutics, and Merck & Co.
Manik Kuchroo invests through Polaris Partners, which writes checks of $500K to $10M at seed, series a.
A warm intro from a founder Polaris Partners backed works best.
Computational Genomics research group at Merck & Co.; business development at Potenza Therapeutics; clinical development at Biohaven Pharmaceuticals.
Last updated 2026-10-15. Is this you? Ask for a correction.